3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Stomach Neoplasms
4
Biliary Tract Neoplasms
2
Pancreatic Neoplasms
1
Nasopharyngeal Carcinoma
1
Malignant Neoplasms of Digestive Organs
1
Klatskin Tumor
1
Gallbladder Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Epstein-Barr Virus Infections
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Bile Duct Neoplasms
1
Advanced Biliary Tract Carcinoma
1
Interventions
Oxaliplatin
19
pembrolizumab
13
Fluorouracil
12
Leucovorin
11
Capecitabine
11
Paclitaxel
10
Gemcitabine
8
Docetaxel
8
zolbetuximab
6
cemiplimab
6
Cisplatin
6
Albumin-Bound Paclitaxel
6
durvalumab
5
Ramucirumab
5
Radiotherapy
5
Irinotecan
4
Cyclophosphamide
4
130-nm albumin-bound paclitaxel
4
trastuzumab deruxtecan
3
tislelizumab
3
lenvatinib
3
enzalutamide
3
darolutamide
3
Trastuzumab
3
Taxes
3
S 1 (combination)
3
Radiosurgery
3
Pemetrexed
3
Nivolumab
3
Carboplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
Tegafur
×
1 year
×
Clear all
No trials found.